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Background: During the first trimester of pregnancy, trophoblastic E-cadherin expression is down-regulated,
thereby allowing extravillous trophoblasts (EVTs) to acquire the potential for migration and invasiveness. The aim of
the present study was to investigate the role of OSM on the migration and proliferation of EVT cell line HTR8/SVneo
with regard to its effects on the expression of E-cadherin and STAT3 activation.
Methods: We investigated the effects of OSM on RNA and protein expression of E-cadherin by real time RT-PCR
analyses, western blotting, and indirect immunofluorescence staining in HTR8/SVneo cells, as well as the effects on
cell migration and proliferation. The selective signal transducer and activator of transcription (STAT)3 inhibitor,
stattic, and STAT3 siRNA were used to investigate STAT3 activation by OSM.
Results: OSM significantly reduced RNA and protein expression of E-cadherin. Indirect immunofluorescence
staining of HTR8/SVneo cells also revealed the down-regulation of E-cadherin, compared with the controls.
OSM-stimulated cell migration was attenuated by anti-gp130 antibodies. OSM-induced STAT3 phosphorylation,
and the down-regulation of E-cadherin by OSM treatment was restored by stattic and STAT3 siRNA. In addition,
OSM-stimulated migration and proliferation were significantly suppressed by STAT3 inhibition.
Conclusions: This study suggests that OSM stimulates the migration and proliferation of EVTs during the first
trimester of pregnancy through the down-regulation of E-cadherin. In addition, this study suggests that the
effects of OSM on migration and proliferation are related to STAT3 activation, which is important in trophoblast
invasiveness.
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In early pregnancy, extravillous trophoblasts (EVTs) in-
vade through the endometrium, interact with decidual
and immunocompetent cells, and differentiate into
multinucleated placental bed giant cells. In addition,
they can invade the maternal spiral arteries, mediate the
destruction of the arterial wall, and replace the endothe-
lium by forming endovascular trophoblasts [1,2].* Correspondence: jcshin@catholic.ac.kr
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reproduction in any medium, provided the orDuring early pregnancy, the invasion of human tropho-
blast cells into the uterus is one of the essential events
for the establishment of a successful pregnancy. It has
been proposed that the processes by which placental
cytotrophoblast cells change phenotypes from being coher-
ently attached to being migratory, where cells invade the
maternal decidua, resemble other developmental epithelial
mesenchymal transitions (EMTs) [3-5]. Because this transi-
tion is critical in normal placental development, growth,
migration, and invasion, it raises the question as to which
factors regulate these migratory events and how the altered
regulation of this transition might manifest pathologically.
Given the importance of the modulation of cell-cellThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cell adhesion and invasion in the placenta might lead to the
further understanding of the early events surrounding pla-
cental development in normal and pathological pregnan-
cies. The modulation of cell adhesion and cell polarity
occurs through changes in cell-cell junctional molecules
such as cadherins. Cadherins, particularly the classical
cadherins (e.g., epithelial (E)-cadherin), and their linkage to
adaptors called catenins, at cell-to-cell contacts, are import-
ant for maintaining cell attachment and the layered pheno-
type of villous cytotrophoblasts. In contrast, the reduced
expression and re-organization of cadherins from these cell
junctional regions promotes the loosening of connections
between cells and reduced apico-basal polarity.
Oncostatin M(OSM) is a member of the interleu-
kin (IL)-6 family of cytokines, which includes IL-6,
leukemia inhibitory factor (LIF), ciliary neurotrophic factor,
cardiotrophin-1, IL-31, and IL-11. OSM is a pleiotropic
cytokine secreted by neutrophils, macrophages, and acti-
vated T cells. OSM is known to be elevated in patients with
rheumatoid arthritis and chronic periodontal disease, and
it plays a significant role in the inflammatory process [6].
In addition, OSM can act as either a stimulator or an in-
hibitor in the regulation of proliferation and differentiation.
Little is known about the effects of OSM on pregnancy,
although OSM concentrations in the sera of pregnant
women were found to be significantly higher than that in
the sera of non-pregnant women, throughout the preg-
nancy period [7,8]. It is possible that OSM may affect the
invasion and migration processes of the EVTs through
various mechanisms, including its effect on EMT during
early pregnancy. Our previous in vitro study demonstrated
that OSM increases the invasion of EVTs in a first trimes-
ter EVT cell line [9]. It has been reported that the loss of
E-cadherin with an increase of snail, which represses the
transcription of E-cadherin, is accompanied with an EMT
in trophoblasts [10]. The aim of the present study was to
investigate the role of OSM on EVT migration and prolif-
eration with regard to its effects on the expression of E-




The EVT cell line HTR8/SVneo was kindly provided by
Dr. Charles Graham (Queen’s University, Kingston, ON,
Canada). The cell line was produced by immortalization of
HTR8 cells, an EVT cell line from primary explant cultures
of first-trimester human placenta (8- to 10-week gestation),
with SV40 [11]. These cells exhibit markers of primary
EVT cells, including the cytokeratins KRT7, KRT8, and
KRT18, placental-type alkaline phosphatase, high-affinity
PLAUR, human leukocyte antigen (HLA) framework anti-
gen W6/32, HLA-G, insulin-like growth factor 2 (IGF2)mRNA, and a selective repertoire of integrins such as
ITGA1, ITGA3, ITGA5, ITGAV, ITGB1, and ITGAVB3/
B5 [12,13]. In the present study, HTR8/SVneo cells were
used between passages 70 and 75.
Cell culture
HTR8/SVneo cells were cultured in RPMI1640 (GIBCO,
Grand Island, NY, USA) containing 10% FBS. To analyze
the effects of OSM on E-cadherin in HTR8/SVneo cells,
107 cells were seeded in a 100-mm culture dish. After
24 h, the cells were treated with recombinant human
OSM (20 ng/mL; Sigma-Aldrich, St. Louis, MO, USA)
for the time indicated in the figure legends.
Real-time quantitative RT-PCR analysis
Total RNA was extracted with TRIZOL reagent (GIBCO-
BRL, Int). The sequences of the primers used for real-time
PCR analysis for E-cadherin (GenBank Accession No.
NM_004360.3) and GAPDH (used as an internal control)
were as follows: E-cadherin (Forward 5′-CGC GTC CTG
GGC AGA GTG AAT TTT G-3′); GAPDH (Forward, 5′-
CGG AGT CAA CGG ATT TGG TCG TAT-3′) [14].
cDNA synthesis
cDNA was synthesized with 500 ng of RNA using the
Superscript™ ∥ RT-PCR System (Invitrogen, Karlsruhe,
Germany) according to the manufacture’s recommenda-
tions. cDNA was diluted 1:2 prior to use in quantitative
PCR.
Quantitative TaqMan PCR
PCR was performed in an ABI PRISM 7900HT Sequence
Detection System (Applied Biosystems, Foster City, CA,
USA) in 384-well microtiter plates, with a final volume of
10 μL. Optimum reaction conditions were established by
using 5 μl of Universal Master Mix (Applied Biosystems,
Foster City, CA, USA) containing dNTPs, MgCl2, reac-
tion buffer and Ampli Taq Gold, 90 nM of primer(s) and
250 nM fluorescence-labeled TaqMan probe. Finally, 2 μl
template cDNA was added to the reaction mixture. The
primer/TaqMan probe combinations were designed for
each target sequence. The assay ID for the E-cadherin
probe was Hs01023894_m1 (Life technology). The ther-
mal cycling conditions used were as follows: an initial
DNA denaturation step at 95°C for 10 min, followed by
40 cycles of denaturation at 95°C for 15 s, primer
annealing at 60°C for 1 min, and an extension step at 72°C
for 15 s. All samples were amplified in triplicate, and data
were analyzed with Sequence Detector software (Applied
Biosystems).
Western blot analysis
The HTR8/SVneo cells were seeded in 6-well cell cul-
ture plates (0.1 × 106 cells per well) in RPMI-1640
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70–80% confluency. The cells were incubated for 48 h,
with or without OSM (20 ng/mL). After incubation, the
cells were washed with Dulbecco’s Phosphate-Buffered
Saline (DPBS), and protein was extracted using RIPA
lysis and extraction buffer (Pierce, USA). Next, 1 mL of
extracted protein was centrifuged at 12,000 rpm for
10 min to remove the residual cell sediment and was
quantified using BCA protein assay reagent (Pierce,
USA). Then, 50 μg of protein were mixed with 5× sam-
ple loading buffer (Fermentas, Canada) and denatured at
100°C for 5 min. The mixture was then subjected to
electrophoresis on an 8–16% SDS-PAGE gel (Koma Bio-
tech, Korea) at 125 V for 2.5 h and then transferred to a
nitrocellulose membrane (Genescript, USA). We used
GAPDH (Santa Cruz, USA) as a loading control. After
the transfer, the membrane was blocked for 1 h with
Noise-Cancelling Reagents (Millipore, USA) and then in-
cubated overnight at 4°C with a mouse anti-human E-
cadherin (1:100) (Santa Cruz, USA). Membranes were
rinsed in 10 mM Tris, 150 mM NaCl (TBS) and 0.1%
Tween 20 prior to, and after incubation with horseradish
peroxidase-conjugated anti-mouse IgG (ICN Biomedicals,
Aurora, OH). Chemi-luminescence was detected with
Luminata Crescendo Western HRP substrate (Millipore,
USA) and autoradiography film (Agfa, Belgium) according
to the manufacturer’s instructions. The experiment was
replicated 3 times. The western blot bands were quantified
by Gel Doc™ XR+with Image lab software (Bio Rad, USA).
Signal transducer and activator of transcription (STAT)3
phosphorylation by OSM
The HTR8/SVneo cells (0.1 × 106 cells per well) were
seeded in 6-well cell culture plates in RPMI-1640
medium supplemented with 10% FBS and cultured until
70–80% confluency was reached. The cells were treated
with OSM (20 ng/mL) for 5 min, 15 min, 30 min, 1 h,
3 h, or 8 h. The control cells were incubated for 8 h
without OSM. The western blot protocol was the same
as that described above except that the antibodies used
were as follows: mouse anti-human phosphorylated
(phosphorylation of Tyr705) STAT3 (1:200) and mouse
anti-human total STAT3 (1:50) (Santa Cruz, USA). The
effect of OSM on STAT3 phosphorylation was examined
following pretreatment with 1 μM stattic for 1 h (Tocris,
R&D system).
The effect of STAT3 inhibition on OSM-mediated changes in
E-cadherin in HTR8/SVneo cells
HTR8/SVneo cells (0.1 × 106 cells per well) were seeded
in 6-well cell culture plates in RPMI-1640 medium
supplemented with 10% FBS and cultured until 70–80%
confluency was reached. The cells were treated with
OSM (20 ng/mL) for 48 h with or without stattic(0.5 μM or 1 μM for 1 h) pretreatment prior to western
blotting. The subsequent steps were the same as de-
scribed above.
STAT3 siRNA and transfections The double-stranded
siRNA oligonucleotide against STAT3 has the sequence
5′-AATGTTCTCTATCAGCACAAT-3′ [15]. Oligonu-
cleotides were synthesized by Genolution Pharmaceuti-
cals, Inc. (Seoul, Korea). Negative controls consisted of a
well-tested non-targeting scrambled siRNA with no
homology to mammalian genes. HTR-8/SVneo cells
were seeded in 6-well plates just prior to transfection.
For optimum transfection efficacy, cells were seeded to a
final cell confluency of 30–50%. Cells were transfected
with either STAT3 siRNA (25 nM) or scrambled siRNA
(25 nM) complexed with G-Fectin (Genolution Pharma-
ceuticals, Inc., Seoul, Korea) for 24 h. After treatment
with OSM (20 ng/mL) for 48 h, cells were dislodged
from the surface of 6-well culture plate for western
blotting.
Indirect immunofluorescence
Cells were cultured on microscope cover slips (diameter,
12 mm; Marienfeld GmbH & KG, Germany). Thereafter,
the cells were stimulated with 20 ng/mL OSM or left
untreated for 48 h, with or without stattic (1 μM for
1 h) pretreatment, and then fixed with 4% paraformalde-
hyde (Wako, Japan) in 0.01 M phosphate-buffered saline
(PBS pH 7.4) for 5 min at room temperature. Next, these
cells were incubated in 2% BSA containing 0.1% Triton
X-100 for 30 min at room temperature. Triton was used
for permeabilization. We tested several blocking methods
and solutions and found that 2% BSA was ideal as a
blocking solution. Cells were then incubated with a mouse
anti-human monoclonal antibody against E-cadherin
(1:100; BD Transduction Laboratories) in blocking solu-
tion for 1 day at 4°C, to allow good penetration of the pri-
mary antibodies. The cells were washed in PBS and
incubated in the presence of appropriate secondary anti-
bodies conjugated with Cy3 (1:1000; Jackson Immuno
Research) for 2 h at room temperature. The fluorescent
specimens were mounted using Vectashield mounting
media (Vector Laboratories, Burlingame, CA). Digital
images (1,024 × 1,024 pixels) were acquired using a Zeiss
LSM 510 Meta confocal microscope (Carl Zeiss Co. Ltd.,
Germany) and were imported into Photoshop (Adobe Sys-
tems, San Jose, CA). We used Photoshop software to de-
crease the background on confocal images with DAPI
staining, and adjusted contrast of the DIC images to im-
prove visualization of the cell morphology. Next, the cells
were treated with OSM (20 ng/mL) for 48 h with or with-
out pretreatment with stattic (1 μM for 1 h) for indirect
immunofluorescence staining. The next steps were the
same as those described above.


















































Figure 1 Effects of OSM (20 ng/mL) on mRNA and protein
expression of E-cadherin in extravillous cytotrophoblast cells
(HTR8/SVneo). Total RNA was extracted from the cells, with or
without OSM stimulation for 48 h, and mRNA levels were measured
by real-time quantitative RT-PCR analysis (A). E-cadherin mRNA levels
were standardized to GAPDH mRNA levels. Results are presented as
means ± SEM of 3 independent experiments. The representative
effects of OSM on E-cadherin as observed from the western blots
are shown in relation to the control (48 h) (B). Quantitative results
(C) of western blots were normalized to GAPDH and presented as a
fold change over the controls (untreated = 1). Data shown are the
means ± SEM of 3 independent experiments compared to the
control (*p < 0.05).
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Cell wounding assays were also conducted as described by
Jones et al. [16], with minor modifications. Briefly, 5 × 105
HTR8/SVneo cells were plated in 6-well plates in 2 mL
medium. The cells were then incubated in a humidified
chamber with 5% CO2 at 37°C until they reached conflu-
ence, and were then wounded using a sterile pipette tip,
leaving a denuded area and a sharp demarcation line.
Monolayers were then rinsed 4 times with s-PBS to remove
the scraped cells. The cells were incubated for 12 h at 37°C
in 5% CO2 with or without OSM (20 ng/mL) or function-
blocking anti-gp130 antibodies (10 μg/mL; R&D system),
and then photographed. Wound closure was assessed using
a LEICA DM IRB/DC 300 microscope (Germany) at 100×
magnification. Cell migration distance was measured using
Olympus 6.51 software and compared with baseline mea-
surements. To evaluate the effects of stattic (1 μM) on
OSM-induced cell migrations, cells were incubated for 12 h
at 37°C in 5% CO2 with or without OSM (20 ng/mL) or
stattic (1 μM) and then photographed. The migration assay
was performed as described above. Experiments were re-
peated at least 3 times in duplicate.
Proliferation assay
HTR8/SVneo cells (1 × 104) were plated in 96-well plate
in a final volume of 100 μl/well culture medium in the
absence or presence of OSM and stattic. Cells were in-
cubated for 12 h and 48 h. After adding 10 μl of water-
soluble tetrazolium (WST) reagent (Biovision, CA, USA)
to each well, cells were incubated for 4 h in standard
culture conditions. The absorbance of the samples was
measured using a 96-well plate reader at 450 nm. The
reference wavelength was 650 nm. Experiments were re-
peated at least 3 times in duplicate.
Statistical analysis
Data are expressed as mean ± SEM. The non-parametric
Mann–Whitney rank-sum test and an independent t-test
were used to compare the 2 groups. A p-value of 0.05 or
less was considered to be statistically significant. Each
experiment was performed 3 times.
Results
Effects of OSM on mRNA and protein expression of
E-cadherin in HTR8/SVneo cells
OSM (20 ng/mL) significantly reduced E-cadherin RNA
and protein expression, compared to the control group
(p < 0.05, respectively), after 48 h stimulation (Figure 1).
STAT3 phosphorylation is stimulated by OSM in HTR8/
SVneo cells
Basal levels of STAT3 phosphorylation were very low,
although stimulation with OSM led to immediate and
transient increases in phosphorylation (Figure 2A).Total STAT3 protein expression did not change sig-
nificantly at any time point. Stattic (1 μM for 1 h), a
STAT3 inhibitor, suppressed OSM-induced STAT3 phos-
phorylation (0.6-fold, p < 0.05) in HTR8/SVneo cells
(Figure 2B).
OSM 20ng/ml



























































Figure 2 (See legend on next page.)
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Figure 2 Effects of OSM, STAT3 inhibitor, and STAT3 siRNA on protein expression of STAT3, phosphorylated STAT3 and E-cadherin.
STAT3 phosphorylation in HTR8/SVneo cells was transiently stimulated with OSM (A). The effect of OSM on STAT3 phosphorylation was checked
by pretreatment with stattic (1 μM for 1 h) compared to the OSM treatment, *p < 0.05 (B). Cells were pretreated with the STAT3 inhibitor stattic
(0.5 and 1 μM) for 1 h prior to treatment with or without OSM (20 ng/mL). Protein expression of E-cadherin was analyzed by western blotting (C).
The expression was quantified, and the values shown are means ± SEM (D) compared to the control, *p < 0.05. Western blots of STAT3,
phosphorylated STAT3, and E-cadherin analyzed 24 h after transfection (E). STAT3 and phosphorylated STAT3 protein expressions were reduced
significantly after siRNA transfection compared with non-transfected control cells (p < 0.05, p < 0.05, 63.6% and 74.3%, respectively), whereas
transfection with a non-targeted siRNA had no effect on STAT3 protein expression levels. Western blots of E-cadherin protein show significantly
restored E-cadherin expressions (p < 0.05, 75.6%), compared to the OSM-induced E-cadherin suppression without affecting GAPDH protein
expression. Non-targeted negative control siRNA did not affect OSM-induced E-cadherin suppression. The results are representative of 3
independent experiments.
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expression in HTR8/SVneo cells
To investigate the role of the STAT3 pathway in the OSM-
induced downregulation of E-cadherin, HTR8/SVneo cells
were pretreated with stattic (0.5 or 1 μM), which has been
reported to inhibit the phosphorylation of STAT3, and then
stimulated with OSM (20 ng/mL, 48 h). In western blot-
ting, the expression of E-cadherin, which was suppressed
by OSM, at 48 h, was restored by stattic pretreatment re-
gardless of the concentration used (Figure 2C and D).
Effect of STAT3 siRNA on OSM-mediated changes in
E-cadherin expression in HTR8/SVneo cells
Applying the described siRNA method and oligonucleotide
sequence, the cellular contents of STAT3 and phosphory-
lated STAT3 were significantly decreased (p < 0.05, 63.6%
and 74.3%, respectively) in HTR8/SVneo cells when 25 nM
relevant oligos, but not when scrambled oligos were used,
as analyzed by western blotting (Figure 2E). Transfection
of HTR8/SVneo cells with STAT3 siRNA significantly in-
creased E-cadherin expression (p < 0.05, 75.6%) which was
suppressed by OSM without affecting the expression of the
GAPDH protein. Non-targeted negative control siRNA did
not affect the expression of STAT3 and E-cadherin
expression.
Effects of OSM and STAT3 inhibitor on E-cadherin in
HTR8/SVneo cells by indirect immunofluorescence
staining
After 48 h of incubation in the presence of OSM, HTR8/
SVneo cell staining revealed a downregulation of E-
cadherin compared with the controls (Figure 3A and B).
There was no specific change in the expression of E-
cadherin, with or without stattic pretreatment (Figure 3A
and C). E-cadherin expression after pretreatment with
stattic and after 48 h incubation with OSM was similar to
the expression in unstimulated cells (Figure 3A and D).
Effects of OSM and STAT3 inhibitor on in vitro
trophoblast migration
OSM induced a significant increase in cell migration dis-
tance—182.2% (p < 0.01) of the control—after 12 h ofculture (Figure 4). Numerical data were evaluated statis-
tically and are presented in the histogram shown in
Figure 4B. When the anti-gp130 antibody (10 μg/mL)
was used to treat the cells, the migration distance in-
creased to 131.1% of the control (p < 0.05).
Relevance of the STAT3 signaling pathway in the
OSM-mediated migration of HTR8/SVneo cells
Stattic was used to investigate the relevance of STAT3-
associated signaling in the OSM-mediated migration of
HTR8/SVneo cells. Treatment of cells with a non-
cytotoxic concentration of stattic (1 μM) resulted in a
significant decrease (65.1%, p < 0.05) in migration com-
pared with the vehicle control (Figure 5). Furthermore,
when cells were co-treated with stattic and OSM, signifi-
cantly increased migration by OSM 139.9%, p < 0.05) be-
came not significant, compared with the control.
Effects of OSM and STAT3 inhibitor on in vitro
trophoblast proliferation
OSM induced a significant increase in cell proliferation—
2.1 fold (p < 0.01) of the control—after 48 h of culture, al-
though OSM did not induce a significant increase after
12 h of culture (Figure 6). Numerical data were evaluated
statistically and are presented in a histogram. Cells were
co-treated with stattic (1 μM) and OSM to investigate the
relevance of STAT3-associated signaling in OSM-induced
proliferation. A significant decrease (p < 0.05) in prolifera-
tion was observed compared with cells treated with OSM
alone, at the 48 h experiment (Figure 6B).
Discussion
Tissues normally consist of epithelial or mesenchymal
cells. Epithelial cells may be induced to change to a
mesenchymal phenotype through EMT, an organized
process first recognized in developmental biology as a
means of achieving morphogenetic changes. In the in-
stances where EMT is not controlled, pathologies arise
whereby cell growth, proliferation, migration, and inva-
sion are altered. A key example of this is carcinoma pro-
gression, whereby cells, which normally show resting
epithelial morphologies, acquire a mesenchymal migratory
Figure 3 Indirect immunofluorescence staining of E-cadherin. Compared with unstimulated cells (A), incubation of HTR8/SVneo cells in the
presence of 20 ng/mL OSM for 48 h resulted in a robust downregulation of E-cadherin (B), whereas there was no significant expression change
after pretreatment with stattic (1 μM, 1 h) (C). The expression of E-cadherin after pretreatment with stattic and 48 h incubation with OSM was
similar to the expression of E-cadherin in unstimulated cells (D). Results shown are representative of 3 independent experiments. Magnification,

























Figure 4 HTR8/SVneo cell migration assessed by cell wounding assay. The effect of OSM (20 ng/mL) with or without anti-gp130 antibodies
(10 μg/mL) on the migration distance of cells after 12 h of culture (A). Cell migration distance was measured using Olympus 6.51 software and
compared with baseline measurements. Three independent experiments were performed. Numerical data were evaluated statistically and are
presented as a histogram (B). Data are expressed as the percentage of untreated control values given as mean ± SEM, with significant differences
at *p < 0.01 for OSM and +p < 0.05 for OSM and anti-gp130 antibodies, compared to the control. A representative result from 3 experiments is
shown in (A).
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Figure 5 Effects of STAT3 inhibition on OSM-induced migrations in HTR8/SVneo cells. Cells were incubated for 12 h at 37°C in 5% CO2
with or without OSM (20 ng/mL), or with or without pretreatment with stattic (1 μM) for 1 h. Cell wounding assays were conducted and assessed
using an LEICA DM IRB/DC 300 microscope (Germany) at 100× magnification. Cell migration distance was measured using Olympus 6.51 software
and compared with baseline measurements. Three independent experiments were performed. A representative experiment from these
experiments is shown in (A). Results were expressed as a percentage of the control (means ± SEM) (B) compared to the control, *p < 0.05.
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to an epithelial phenotype [17,18]. The expression of
epithelial markers is reduced, while mesenchymal marker
expression is increased. OSM has been identified as an
EMT factor in lung and pancreatic tumor models [19]. It
has also recently been reported that oncostatin-M pro-






























Figure 6 The effects of OSM and STAT3 inhibitors on in vitro trophob
in cell proliferation after 24 h of culture (A), but induced a significant incre
the control (B). Cell proliferation was significantly decreased with stattic (1
experiment (B), not at 12 h experiment (A). There was no significant differe
OSM with stattic and the control (A and B). Data shown are means ± SEM
measured using a 96-well plate reader at 450 nm. The reference wavelengt[20]. In human renal tubular cells, it has been shown that
OSM induces EMT through the Jak/Stat pathway and
ERK signaling [21,22].
E-cadherin is usually expressed in epithelial cells and is
involved in calcium-dependent cell-cell adhesion. In the
placenta, E-cadherin mediates a strong intercellular inter-







control OSM stattic O+SOSM + stattic
h 84
last proliferation. OSM (20 ng/mL) did not induce significant increase
ase in cell proliferation after 48 h of culture to 2.1-fold (*p < 0.01) of
μM) treatment, compared to the control (+p < 0.05), at 48 h
nce in cell proliferation between the results of the co-treatment of
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h was 650 nm.
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is temporarily down-regulated so that the EVTs acquire in-
vasiveness [23]. Recent studies support the important role
of E-cadherin in the regulation of the invasive behavior of
human trophoblast cells [10,24].
In the present study, we used real-time PCR analysis,
western blotting, and indirect immunofluorescence stain-
ing to demonstrate that the expression of the epithelial
marker E-cadherin was significantly decreased by OSM.
We also demonstrated that OSM stimulated the migration
of HTR8/SVneo cells and that the addition of an anti-
gp130 antibody decreased the stimulatory effects of OSM
on migration. OSM belongs to the IL-6 family of cytokines
and acts on target cells by binding to a heterodimeric
membrane receptor composed of LIF- or OSM-specific
receptor and the gp130 receptor chain [25]. In addition,
OSM stimulated the proliferation of HTR8/SVneo cells at
48 h assay, not at 12 h assay. It is considered that signifi-
cant increase in cell migration distance by OSM (12 h)
represents an increased migration by OSM, because pro-
liferation has not been changed significantly at 12 h assay.
It has been shown that phosphorylated STAT3 enhances
the invasiveness of tumors and trophoblast cells, where it
is mainly activated by LIF [26]. We demonstrated that
the migration and proliferation of trophoblasts are
stimulated, E-cadherin is suppressed by OSM, and that
these events are related to STAT3 phosphorylation. The
down-regulation of E-cadherin by OSM was restored
following treatment with a STAT3 inhibitor. In addition,
OSM-stimulated migration and proliferation were signi-
ficantly suppressed by STAT3 inhibition. Because it has
been recently reported that a STAT3 inhibitor, stattic, has
limitations to inhibit STAT3, selectively [27], we investi-
gated the STAT3 pathway with STAT3 siRNA. The
down-regulation of E-cadherin by OSM was restored
following treatment with a STAT3 siRNA, with the
same pattern. These results suggest that OSM stimu-
lates the migration and proliferation of trophoblasts
through STAT3 signaling, although the other pathway
could be engaged by OSM, with or without STAT3
signaling.
No data regarding the effects of OSM on EMT in
EVTs have yet been published. It has been reported that
a significantly higher expression of OSM was identified
in the cytotrophoblasts, syncytotorophoblasts and endo-
thelium of the preeclamptic placenta compared with the
normal placenta [8]. On the basis of the present study,
OSM was found to induce the migration and prolifera-
tion of EVTs, through the down-regulation of E-
cadherin. The effects of OSM on E-cadherin observed
and the migration and proliferation of EVTs were con-
trary to observations that the invasion of EVT is shallow
and that expression of OSM is elevated in the pre-
eclamptic placenta [10,28-30]. The elevated expressionof OSM in the preeclamptic placenta could be an adap-
tive phenomenon to rescue the shallow invasion of EVT.
Another possibility is that the increased expression of
OSM in preeclampsia may not be related to the effects
of OSM on migration, proliferation, and invasion of
EVTs, but instead could be related to the other effects of
OSM. However, we do not yet know the effects of OSM
on trophoblast migration, proliferation, and the invasion
of EVTs in hypoxic environments. Recently, it was
reported that recombinant interleukin-6 (IL-6) and
TNFα were capable of activating endothelial cells, which
is a hallmark of preeclampsia [31]. Another study dem-
onstrated that IL-6 stimulates cell migration and inva-
sion accompanied by the increased expression of related
integrin subunits on the HTR8/SVneo cell line [32], al-
though the former study only suggested the effects of
IL-6 on EVT invasion cellular cascades [33]. LIF, a mem-
ber of the IL-6 family, has been suggested to increase
the invasiveness of trophoblastic cells through the acti-
vation of STAT1 or STAT3 [26,34]. Because OSM is a
cytokine in the IL-6 family, its role in activating endo-
thelial cells should be investigated to evaluate the role of
OSM in the preeclamptic placenta [31,32]. The func-
tional role of OSM in the human placenta has not yet
been clarified. Because OSM has cell-type specific ef-
fects, the effects and mechanisms of OSM related to
normal and pathologic pregnancies should be evaluated
both in vitro and in vivo.
Conclusions
Taken together, these data suggest a contributing role for
OSM in stimulating the migration of EVTs during the
first trimester through down-regulation of E-cadherin.
The effects of OSM on E-cadherin and the migration of
the trophoblasts were related to STAT3 activation, which
is important for trophoblast invasiveness. Further re-
search is needed to investigate the various roles of OSM
in normal and pathologic pregnancies under hypoxic
conditions, including how this cytokine interacts with
other regulating molecules.
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